ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q907. A total of 4 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $437,000 | – | 3,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Marathon Trading Investment Management LLC | 3,000 | $437,000 | 0.03% |
GROUP ONE TRADING, L.P. | 45,100 | $6,567,000 | 0.02% |
SIMPLEX TRADING, LLC | 340 | $4,950,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |